Please try another search
Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers intermediates, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil, chlorpheniramine maleate, clopidogrel bisulfate, lidocaine, febuxostat, esomeprazole sodium, and esomeprazole magnesium. The company was formerly known as Henan Newland Pharmaceutical Co., Ltd. and changed its name to Newland Pharmaceutical Co., Ltd. in June 2023. Newland Pharmaceutical Co., Ltd. was founded in 2005 and is based in Changge City, China.
Name | Age | Since | Title |
---|---|---|---|
Wanmin Liu | 56 | - | Vice Chairman |
Jianzhong Xie | 59 | 2009 | Chairman of the Board |
Luwei Zhang | 53 | 2009 | GM & Director |
Heping Xu | 66 | 2015 | Supervisory Board Chairman |
Chao Liu | 38 | 2019 | Deputy GM & Director |
Binggang Zhang | 62 | 2009 | Director |
Jindeng Li | 44 | 2020 | Director & Board Secretary |
Jingbao Wang | 61 | 2020 | Independent Director |
Hongmin Liu | - | 2024 | Non-Independent Director |
Yu Ke | 53 | 2021 | Independent Director |
Changchun Liu | 59 | 2020 | Supervisor |
Faliang Jia | 58 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review